The objective of the project is to develop a fast and robust nucleic acid based detection platform for diagnosis of infectious diseases from body fluids. Developed platform would be based on isothermal nucleic acid amplification and detection. The platform is suitable to use directly in one step cost effective rapid test devices. The test device applicable for clinical, field and home use will be developed during the project. This requires well-weighted design of the device considering the whole functionality with user friendly operation.

The consortium is coordinated by an Estonian SME and also contains a university from Estonia. In order to complete the consortium, additional partners are sought.

SME medical device developers and producers are soight to design the test device and production process. Suitable SMEs have cross-functional expertise and knowledge over all product development process. Partners’ main role is to:
• engineer and miniaturize detection platform into small and disposable point of care test device using microfluidic, lateral flow, smart material, etc. technological solutions,
• evaluate consumer needs, shape the product through design, determine the technological process by which the product will be made, and consider the interface between the product and the end user,
• design the production process and assist in the evaluation of the product’s profit potential and ensure that the product can be manufactured in full-scale production,
• validate the test device and production process to ensure compliance with legal and other requirements.

Ideally, the partners already have an established position in the market of diagnostics devices.